Regulaxis SAS

About:

Regulaxis is focused in research, development and licensing of human innovative synthetic molecules for high unmet medical needs

Website: http://regulaxis.com/

Twitter/X: regulaxis

Top Investors: EASME - EU Executive Agency for SMEs

Description:

Regulaxis mission is to grant licenses of innovative molecules after phase II clinical records.

Total Funding Amount:

3.21M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Romainville, Ile-de-France, France

Founded Date:

2013-12-01

Contact Email:

regulaxis(AT)regulaxis.com

Founders:

Claude Carelli

Number of Employees:

1-10

Last Funding Date:

2018-07-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai